| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019906897 |
| P356 | DOI | 10.1038/SJ.GT.3301231 |
| P698 | PubMed publication ID | 10918491 |
| P5875 | ResearchGate publication ID | 12400436 |
| P2093 | author name string | Rigal D | |
| Divita G | |||
| Baggetto LG | |||
| Bernaud J | |||
| Marthinet E | |||
| P2860 | cites work | Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line. | Q54313706 |
| Non-radioisotopic AFLP method using PCR primers fluorescently labeled with Cy5 | Q57220600 | ||
| The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein | Q58449756 | ||
| Efficient purification and reconstitution of P-glycoprotein for functional and structural studies | Q71763325 | ||
| Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides | Q72211702 | ||
| Cellular uptake and intracellular fate of antisense oligonucleotides | Q75294069 | ||
| Intracellular localization of oligonucleotides: influence of fixative protocols | Q77227625 | ||
| Modulation of estrogen receptor gene expression in human breast cancer cells: a decoy strategy with specific PCR-generated DNA fragments | Q77425702 | ||
| Selective reversal of drug resistance in drug-resistant lung adenocarcinoma cells by tumor-specific expression of mdrl ribozyme gene mediated by retrovirus | Q81825944 | ||
| Isolation and expression of a complementary DNA that confers multidrug resistance | Q24295219 | ||
| Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line | Q24338329 | ||
| Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold | Q24556499 | ||
| The "initiator" as a transcription control element | Q29619589 | ||
| Specific regulation of gene expression by antisense, sense and antigene nucleic acids | Q33256068 | ||
| Binding protein-dependent transport systems | Q34030447 | ||
| Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance | Q34161314 | ||
| A conserved downstream element defines a new class of RNA polymerase II promoters | Q38287842 | ||
| Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth | Q38329699 | ||
| Transcriptional regulation of the human proenkephalin gene by conformational switching: implications for decoy design | Q38337532 | ||
| A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. | Q38344289 | ||
| Progress in antisense oligonucleotide therapeutics | Q38363412 | ||
| A novel potent strategy for gene delivery using a single peptide vector as a carrier | Q39728864 | ||
| Pharmacologic circumvention of multidrug resistance | Q40535280 | ||
| Inactivation of MED-1 elements in the TATA-less, initiator-less mouse thymidylate synthase promoter has no effect on promoter strength or the complex pattern of transcriptional start sites | Q40965649 | ||
| Identification of cis-elements of the human endothelin-A receptor gene and inhibition of the gene expression by the decoy strategy | Q41032627 | ||
| Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras | Q41192006 | ||
| Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoding gene in Chinese hamster lung cells | Q41349156 | ||
| Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells | Q41436576 | ||
| Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies | Q41654976 | ||
| Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative | Q41666601 | ||
| Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease | Q45887776 | ||
| Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysis | Q47961866 | ||
| In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin. | Q54118345 | ||
| Improvement of hammerhead ribozymes cleaving mdr-1 mRNA. | Q54174765 | ||
| Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. | Q54237546 | ||
| Identification of a functional initiator sequence in the human MDR1 promoter. | Q54247377 | ||
| P433 | issue | 14 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 1224-1233 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter | |
| P478 | volume | 7 |
| Q39590850 | A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells |
| Q37615342 | Chemically modified cell-penetrating peptides for the delivery of nucleic acids |
| Q40507972 | Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. |
| Q40756238 | Cytogenetic characterization of chromosomal rearrangement in a human vinblastine-resistant CEM cell line: use of comparative genomic hybridization and fluorescence in situ hybridization |
| Q40722578 | Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. |
| Q34448371 | Multidrug resistance in uveal melanoma |
| Q24562993 | New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein |
| Q30453423 | Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm |
| Q37010772 | Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies |
| Q40514562 | Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells |
| Q44084390 | Reversing antibiotic resistance |
| Q33868054 | Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells |
| Q35567283 | Transcriptional regulation of ABC drug transporters |
| Q34816232 | Transcriptional regulators of the human multidrug resistance 1 gene: recent views |
| Q37230918 | Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics |
Search more.